Lopimune

🧾 Product Overview Table

🧪 About Lopimune (Lopinavir/Ritonavir)

Lopimune is a fixed-dose combination antiretroviral medication that combines Lopinavir and Ritonavir. It is manufactured by Cipla Limited, one of India’s leading pharmaceutical companies known for its pioneering role in HIV/AIDS treatment. This medication is used as part of highly active antiretroviral therapy (HAART) for managing HIV-1 infection in adults and children. Ritonavir acts as a pharmacokinetic enhancer, boosting the effects of Lopinavir by slowing its breakdown in the liver, ensuring higher efficacy.

🎥 Educational Video Guide

Watch a medical video about how Lopinavir/Ritonavir works, its clinical uses, and dosing schedule for HIV management.

👩‍⚕️ Doctor’s Insight

“Lopimune has played a significant role in making second-line HIV treatment more accessible in resource-limited settings. The inclusion of Ritonavir ensures sustained plasma levels of Lopinavir, allowing for more effective viral suppression.”
— Dr. Neha Khurana, Infectious Disease Specialist

💉 Dosage & Administration

Always follow physician guidance and use in combination with other antiretrovirals.

⚠️ Side Effects, Storage & Warnings

• 🤔 Common Side Effects: Diarrhea, nausea, headache, fatigue
• ❗ Serious Risks: Pancreatitis, liver toxicity, high cholesterol, QT prolongation
• ❄️ Storage: Keep in a cool, dry place below 25°C. Protect from moisture.
• ⛔ Avoid use with: Rifampin, certain statins, St. John’s Wort

🌍 Global Availability & Shipping

🔗 Related Indian Alternatives (Same Therapeutic Class)

📖 Authoritative References

• FDA Label – Lopinavir/Ritonavir
• WHO HIV Guidelines
• Drugs.com Profile
• NHS – HIV Treatment Overview

ℹ️ Disclaimer
This information is intended for educational purposes only. Please consult a healthcare provider for personalized medical advice before starting or stopping any medication.